Effect of HER2-low status on brain metastasis-free survival and survival after brain metastasis in patients with breast cancer.
Tuğba ÖnderCengiz KaraçinPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Low HER2 expression does not affect BMFS or SAMB in brain metastatic breast cancer patients in this real-world population.